
IndraLab
Statements
sparser
"Comparison of the crystal structures for the free and Ub bound catalytic core domain of USP14 suggests that the enzyme is activated by conformational translocation of two enzyme surface loops, which block access of the Ub C-terminus to the active site in the free enzyme ( xref )."
sparser
"It is also a reversible non‐selective competitive inhibitor of USP14, targeting the formation of Ub‐USP14 or Ub‐UCHL5 conjugates. xref This is achieved by inhibiting the enzymatic activity of USP14 and UCHL5, and VLX1570 shows significant anti‐cancer impact in multiple myeloma and Waldenstrom's macroglobulinemia. xref Anchored in these findings, a phase 1/2 trial evaluating the efficacy and tolerability of VLX1570 in patients with relapsed or refractory multiple myeloma is currently under way (NCT02372240). xref "
sparser
"Only approximately 1000 Å 2 of the surface area of PL pro (640 Å 2 by the Ub core and 360 Å 2 by the Ub C-terminus) is buried in the interface, which is smaller than in the USP2-Ub (1900 Å 2 ; Supplementary Fig. S6b ), USP14-Ub aldehyde (1500 Å 2 ; Supplementary Fig. S6c ) and HAUSP-Ub aldehyde (1700 Å 2 ) complexes."
sparser
"Usp14’s N -terminal ubiquitin-like domain (UBL) docks onto the proteasome through interacting with Rpn-1’s T2 domain.[ xref ][ xref , xref ][ xref , xref ][ xref , xref ][ xref , xref ][ xref , xref ][ xref , xref ][ xref , xref ][ xref , xref ]A 2016 cryo-EM structure at 4.35 Å resolution was solved of the 26S proteasome bound to the Usp14-ubiquitin aldehyde complex (UbAl, a covalent inhibitor of Usp14 where the C -terminal carboxylate is replaced with an aldehyde), xref .[ xref ]It displayed Usp14’s proximity to Rpn-1 (although the UBL domain appeared to have no density due to its flexibility), and Rpn-1’s position in the 19S RP was observed to undergo the most movement (50-60 Å) when bound to Usp14.[ xref ]While the UBL domain interacts with Rpn-1, Usp14 also interacts with Rpt-1 and Rpt-2 oligosacharide-binding domains to further help dock itself onto the proteasome."
sparser
"Undoubtedly, DUB activity is a promising strategy for cancer therapy. xref VLX1570 targets the Ub‐USP14 or Ub‐UCHL5 conjugates and is a reversible non‐selective competitive inhibitor of ubiquitin peptidase 14 (USP14) and ubiquitin carboxyl‐terminal hydrolase 5 (UCHL5) in multiple myeloma. xref VLX1570 has been shown to have significant anti‐cancer efficacy with high potency and solubility."
sparser
"Not all functions of USP14 at the proteasome depend on its catalytic activity: binding of USP14 to poly-Ub chains and unfolded peptides results in opening of the gates of the 20S proteasome and stimulation of the ATPase activity of the proteasome (Peth et al., xref , xref , xref )."
sparser
"Comparison of the crystal structures for the free and Ub bound catalytic core domain of USP14 suggests that the enzyme is activated by conformational translocation of two enzyme surface loops, which block access of the Ub C-terminus to the active site in the free enzyme (Hu et al., 2005)."